awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37672654-3D3DF71C-91C9-4BDA-8608-C0687EB80CE2
Q37672654-3D3DF71C-91C9-4BDA-8608-C0687EB80CE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37672654-3D3DF71C-91C9-4BDA-8608-C0687EB80CE2
Controlling escape from angiogenesis inhibitors.
P2860
Q37672654-3D3DF71C-91C9-4BDA-8608-C0687EB80CE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37672654-3D3DF71C-91C9-4BDA-8608-C0687EB80CE2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5401b9ee949582aa48ded53ccb75644cc8c29309
P2860
Independent review of E2100: a phase III trial of bevacizumab plus paclitaxel versus paclitaxel in women with metastatic breast cancer.